40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.74%
Revenue decline while CRK shows 30.36% growth. Joel Greenblatt would examine competitive position erosion.
-20.09%
Cost reduction while CRK shows 6.71% growth. Joel Greenblatt would examine competitive advantage.
-14.35%
Gross profit decline while CRK shows 35.72% growth. Joel Greenblatt would examine competitive position.
2.87%
Margin expansion 50-75% of CRK's 4.11%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-43.51%
Other expenses reduction while CRK shows 243.17% growth. Joel Greenblatt would examine efficiency.
-36.15%
Operating expenses reduction while CRK shows 214.06% growth. Joel Greenblatt would examine advantage.
-26.11%
Total costs reduction while CRK shows 123.61% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
9.06%
D&A growth 1.25-1.5x CRK's 6.94%. Martin Whitman would scrutinize asset base.
75.27%
EBITDA growth while CRK declines. John Neff would investigate advantages.
-75.64%
Both companies show margin pressure. Martin Whitman would check industry conditions.
1.92%
Operating income growth below 50% of CRK's 52.42%. Michael Burry would check for structural issues.
22.40%
Operating margin growth 1.25-1.5x CRK's 16.92%. Bruce Berkowitz would examine sustainability.
20692.01%
Other expenses growth above 1.5x CRK's 148.96%. Michael Burry would check for concerning trends.
614.28%
Pre-tax income growth exceeding 1.5x CRK's 202.10%. David Dodd would verify competitive advantages.
757.85%
Pre-tax margin growth exceeding 1.5x CRK's 131.74%. David Dodd would verify competitive advantages.
610.40%
Tax expense growth above 1.5x CRK's 220.26%. Michael Burry would check for concerning trends.
790.82%
Net income growth exceeding 1.5x CRK's 192.34%. David Dodd would verify competitive advantages.
969.87%
Net margin growth exceeding 1.5x CRK's 124.25%. David Dodd would verify competitive advantages.
669.68%
EPS growth exceeding 1.5x CRK's 180.57%. David Dodd would verify competitive advantages.
695.33%
Diluted EPS growth exceeding 1.5x CRK's 197.58%. David Dodd would verify competitive advantages.
16.06%
Share count reduction below 50% of CRK's 2.92%. Michael Burry would check for concerns.
13.32%
Diluted share increase while CRK reduces shares. John Neff would investigate differences.